Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 BV short-term versus long-term treatment for prevention of respiratory tract infections in children with asthma
CTR20230710Phase 4Completed
- Sponsor
- 不适用/ 杭州泰格医药科技股份有限公司
- Start
- Apr 2023
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-85 in Airways Infection, asthma, sponsored by 不适用/ 杭州泰格医药科技股份有限公司. Started Apr 2023; status: completed.
02
Drugs
OM-85
03
Conditions
Airways Infectionasthma
Beyond the preview
Go deeper on CTR20230710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230710.